Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.81−0.01 (-0.05%)
Close on Nov 19, 2026Market cap $935.96MP/E –Yield –
Silence Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Silence Therapeutics's shares outstanding was 166M at Sep 30, 2026. For fiscal 2025 it was 142M, up 2.1% from the year before. The highest annual figure on record is 142M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 142M | +2.1% |
| FY2024 | Dec 31, 2024 | 139M | +24.7% |
| FY2023 | Dec 31, 2023 | 111M | +15.2% |
| FY2022 | Dec 31, 2022 | 97M | +8.6% |
| FY2021 | Dec 31, 2021 | 89M | +8.8% |
| FY2020 | Dec 31, 2020 | 82M | +8.8% |
| FY2019 | Dec 31, 2019 | 75M | +6.8% |
| FY2018 | Dec 31, 2018 | 70M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 166M | +16.9% |
| Q2 FY2026 | Jun 30, 2026 | 142M | +0.0% |
| Q1 FY2026 | Mar 31, 2026 | 142M | +0.0% |
| Q4 FY2025 | Dec 31, 2025 | 142M | +0.0% |
| Q3 FY2025 | Sep 30, 2025 | 142M | +0.4% |
| Q2 FY2025 | Jun 30, 2025 | 142M | +1.1% |
| Q1 FY2025 | Mar 31, 2025 | 142M | +7.4% |
| Q4 FY2024 | Dec 31, 2024 | 142M | – |
| Q3 FY2024 | Sep 30, 2024 | 141M | – |
| Q2 FY2024 | Jun 30, 2024 | 140M | – |
| Q1 FY2024 | Mar 31, 2024 | 132M | – |
See a number that looks wrong?